UNII - FE7L22H028

ZALIFRELIMAB

UNII: FE7L22H028

Preferred Substance Name: ZALIFRELIMAB

2148321-69-9
A HUMAN MONOCLONAL ANTIBODY TARGETING CYTOTOXIC T LYMPHOCYTE ASSOCIATED PROTEIN 4 (CTLA4)
AGEN1884
AGEN-1884
ANTI-CTLA-4 MONOCLONAL ANTIBODY AGEN1884
IMMUNOGLOBULIN G1, ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4) (HUMAN MONOCLONAL AGEN1884 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AGEN1884 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC TLYMPHOCYTE-ASSOCIATED PROTEIN 4, CD152))
UGN-301
ZALIFRELIMAB [INN]
ZALIFRELIMAB [USAN]
ZALIFRELIMAB [WHO-DD]

Common Chemistry
i
Inxight Drugs
i
NCATS GSRS Full Record
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ZALIFRELIMAB

Synonyms and Mappings

Resources

Note